A. Huynh

[Follow-up of the long-term survivors of transplantation and cellular therapy - SFGM-TC].

Continuous advances in allogeneic hematopoietic stem cell transplantation (allo-HSCT) have led to a growing population of long-term survivors. The Long-Term Follow-Up (LTFU) - typically defined as starting beyond two years post-transplant - aims to prevent, detect, and manage late complications, which progressively rep...

GVHD prophylaxis with PTCy, ATG, PTCy+ATG, or no in vivo T-cell depletion in RIC matched-donor PBSC transplantation for AML and MDS.

[Guidelines for the essential data entry in the European Bone Marrow Transplant Registry].

The objective of this workshop is to develop recommendations aimed at harmonizing data entry across all centers, and highlighted the need for stronger collaboration between physicians, cytogeneticists, biologists, and data managers to better identify, define, and standardize the data to be collected.

Improved progression free survival after axicabtagene ciloleucel compared to tisagenlecleucel, in patients aged >70 years with large B-cell lymphoma.

Outcomes included cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), overall survival (OS), progression-free survival (PFS), relapse incidence (RI), and non-relapse mortality (NRM).